Skip to content
healthcare.dev

Ibandronate Sodium

NDC 60505-6097, ibandronate sodium, injection, from Apotex Corp..

Product NDC
60505-6097
Status
Listed
Labeler
Apotex Corp.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204222
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60505-6097 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IBANDRONATE SODIUM3 mg/3mL

Pharmacologic classes

Bisphosphonate [EPC]; Diphosphonates [CS]

Package NDCNDC-11Package
60505-6097-0605056097001 SYRINGE, GLASS in 1 CARTON (60505-6097-0) / 3 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9fad4982-95af-d711-f50a-867311835143
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=60505-6097
  • NADAC price for package 60505609700

    GET /v1/drugs/nadac/60505609700

Use it

Look up 60505-6097 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60505-6097 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60505-6097. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.